Bluebird Bio BLUE Q4 and 2023 Summary 27Mar2024

Channel:
Subscribers:
1,060
Published on ● Video Link: https://www.youtube.com/watch?v=jIyo0Fm74n4



Duration: 6:44
134 views
7


Bluebird Bio BLUE Q4 and 2023 Summary 27Mar2024

Thank you for watching this video If you like it please like the video and subscribe to my page. Please excuse the spelling I just noticed it

If I have gotten anything wrong please write in the comments, and include any links. If it is a small spelling error or pronunciation error, I will not change the video but will work on it in the next video!

If you liked this video please take a moment to subscribe to my channel.
There are more videos posted in the comments

#stocks #microcapstocks #pharmastocks #blue #investing

I have other videos which can be viewed below (in date order)

Lipocine Inc LPCN 2023 Summary 25Mar2024
   • Lipocine Inc LPCN 2023 Summary 25Mar2024  

Assertio Holdings ASRT 4Q and Yearly 2023 Summary 20Mar2023
   • Assertio Holdings ASRT 4Q and Yearly ...  

Protalix BioTherapeutics PLX 4Q and Yearly Summary 18Mar2024
   • Protalix BioTherapeutics PLX 4Q and Y...  

Geron Corp GERN Post ADCOM Summary 15Mar2024
   • Geron Corp GERN Post ADCOM Summary 15...  

Aquestive Therapeutics (AQST) Q4 2023 and Yearly Summary 11Mar2024
   • Aquestive Therapeutics (AQST) Q4 2023...  

Xeris Pharmaceuticals (XERS) Q4 2023 and Full year Summary 07Mar2024
   • Xeris Pharmaceuticals (XERS) Q4 2023 ...  

Geron Corp (GERN) 4Q Quarterly and Pre ADCOM Summary 04Mar2024
   • Geron Corp (GERN) 4Q Quarterly and Pr...  

Palatin Technologies Inc (PTN) P3 Results Summary 29Feb2024
   • Palatin Technologies Inc (PTN) P3 Res...  

Ardelyx (ARDX) 4Q 2023 Summary 23Feb2024
   • Ardelyx (ARDX) 4Q 2023 Summary 23Feb2024  

Elite Pharmaceuticals ELTP Q3 2024 Earnings Summary 20Feb2024
   • Elite Pharmaceuticals ELTP Q3 2024 Ea...  

Palatin Technologies Inc PTN Q2 2024 Summary 16Feb2024
   • Palatin Technologies Inc PTN Q2 2024 ...  

Merrimack Pharmaceuticals MACK Approval Summary 14Feb2024
   • Merrimack Pharmaceuticals MACK Approv...  

Anavex Life Sciences Corp AVXL 1Q 2024 Summary 08Feb2024
   • Anavex Life Sciences Corp  AVXL 1Q 20...  

Palatin Technologies Inc (PTN) Offering Summary 31Jan2024
   • Palatin Technologies Inc (PTN) Offeri...  

Cara Therapeutics (CARA) Summary 29Jan2024
   • Cara Therapeutics (CARA) Summary 29Ja...  

Akebia Therapeutics (AKBA) Summary 22Jan2024
   • Akebia Therapeutics (AKBA) Summary 22...  

Lipocine Inc LPCN Tlando and LPCN 1154 Summary 19Jan2024
   • Lipocine Inc LPCN Tlando and LPCN 115...  

Palatin Technologies Inc (PTN) MELODY-1 Data Delay Summary 16Jan2024
   • Palatin Technologies Inc (PTN) MELODY...  

Xeris Pharmaceuticals (XERS) Licensing deal with Amgen Summary 11Jan2024
   • Xeris Pharmaceuticals (XERS) Licensin...  

Ardelyx (ARDX) Update Guidance Summary 10Jan2024
   • Ardelyx (ARDX) Update Guidance Summar...  

Xeris Pharmaceuticals XERS Guidance Summary 08Jan2024
   • Xeris Pharmaceuticals XERS Guidance S...  

Anavex Life Sciences Corp AVXL Clinical Update Summary 03Jan2024
   • Anavex Life Sciences Corp  AVXL Clini...  

Geron Corp GERN Summary 02Jan2024
   • Geron Corp GERN Summary 02Jan2024  

Palatin Technologies Inc (PTN) Vyleesi Deal Summary 22Dec2023
   • Palatin Technologies Inc (PTN) Vylees...  

Bluebird Bio (BLUE) Wow that’s a lot of dilution Summary 21Dec2023
   • Bluebird Bio (BLUE) Wow that’s a lot ...  







Tags:
Bluebird Bio BLUE Q4 and 2023 Summary 27Mar2024
Bluebird
bluebird bio
bluebird biotech
bluebird bio news
bluebird bio stock
gene editing
biotech
beta thalassemia
nick leschly
bluebird
bad ass bird
car t cancer immunotherapy
childhood cerebral adrenoleukodystrophy
beta thalassemia symptoms
thalassemia
beti cel
eli cel
PDUFA
ZYNTEGLO
SKYSONA
CRISPR
CRISPR Therapeutics
sickle cell anemia
Bluebird Bio BLUE Pre PDUFA Summary 04Dec2023